NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/28/2025
Back to search
Official data from USPTO
INNOCARE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
10
Latest update
01/28/2025
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
03/27/2024
Registration date
01/28/2025
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/28/2025
Last transaction
01/28/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
Changping Dist,Beijing, CN
Examiner
HSU, FONG
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized word INNOCARE.
Holders and representatives
Holders
Beijing InnoCare Pharma Tech Co., Ltd.
Representatives
Dana Stewart-Mekdara Global Trademarks, Inc.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic preparations for medical purposes for detecting the presence of malignantinflammatory and autoimmune disorders and conditions and tissue trauma in humans; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesbacteria-based diseases or disordersautoimmune diseases or disorderskidney diseases or disordersdiabetes; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseasesfor the treatment of cancer
Publications
History of USPTO decisions and trademark events.
10 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/28/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/10/2024
PUBO
PUBLISHED FOR OPPOSITION
12/10/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/04/2024
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
10/17/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/07/2024
DOCK
ASSIGNED TO EXAMINER
10/07/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/27/2024
NWAP
NEW APPLICATION ENTERED
03/27/2024
Continuous trademark protection
Get notified about every new filing that threatens INNOCARE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.